Avalo Therapeutics, Inc. Quarterly Selling and Marketing Expense in USD from Q1 2017 to Q2 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
Avalo Therapeutics, Inc. quarterly/annual Selling and Marketing Expense history and growth rate from Q1 2017 to Q2 2022.
  • Avalo Therapeutics, Inc. Selling and Marketing Expense for the quarter ending June 30, 2022 was $2.8M, a 250% increase year-over-year.
  • Avalo Therapeutics, Inc. Selling and Marketing Expense for the twelve months ending June 30, 2022 was $6.29M, a 180% increase year-over-year.
  • Avalo Therapeutics, Inc. annual Selling and Marketing Expense for 2021 was $2.83M, a 20.7% increase from 2020.
  • Avalo Therapeutics, Inc. annual Selling and Marketing Expense for 2020 was $2.34M, a 57.7% increase from 2019.
  • Avalo Therapeutics, Inc. annual Selling and Marketing Expense for 2019 was $1.48M, a 172% increase from 2018.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2022 $6.29M $2.8M +$2M +250% Apr 1, 2022 Jun 30, 2022 10-K 2023-03-29
Q1 2022 $4.29M $1.9M +$1.47M +337% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $2.83M $891K +$342K +62.3% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-02
Q3 2021 $2.48M $700K +$238K +51.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $2.25M $800K +$147K +22.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $2.1M $435K -$242K -35.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $2.34M $549K +$1.3K +0.24% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-02
Q3 2020 $2.34M $462K +$248K +116% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $2.09M $653K +$327K +100% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-02
Q1 2020 $1.76M $677K +$281K +70.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $1.48M $548K +$5.88M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-08
Q3 2019 -$4.4M $214K -$2.1M -90.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$2.3M $326K -$1.72M -84% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$583K $396K -$1.13M -74% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $545K -$5.33M -$6.31M -648% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-11
Q3 2018 $6.85M $2.31M +$2.31M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $4.54M $2.04M +$2.04M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $2.5M $1.52M +$1.52M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $973K $973K Oct 1, 2017 Dec 31, 2017 10-K 2018-04-02
Q3 2017 $0 Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 $0 Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $0 Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.